Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Heart Rhythm

The EAST-AFNET4 trial showed clinical benefit of systematic, early initiation of rhythm control therapy in patients with atrial fibrillation (AF), with 21% fewer cardiovascular

  • The EAST-AFNET4 trial showed clinical benefit of systematic, early initiation of rhythm control therapy in patients with atrial fibrillation (AF), with 21% fewer cardiovascular events compared to rhythm control given only to symptomatic patients. This authors reply reviews why now our results with earl control are better then those seen with AFFIRM